- Impact of Upper Eyelid Surgery on Symptom Severity and Frequency in Benign Essential Blepharospasm
-
Hannah Mary Timlin, Kailun Jiang, Daniel George Ezra
-
J Mov Disord. 2021;14(1):53-59. Published online January 12, 2021
-
DOI: https://doi.org/10.14802/jmd.20075
-
-
5,880
View
-
114
Download
-
3
Web of Science
-
2
Crossref
-
 Abstract
 PDF
- Objective
To assess the impact of periocular surgery, other than orbicularis stripping, on the severity and frequency of blepharospasm symptoms.
Methods
Consecutive patients with benign essential blepharospasm (BEB) who underwent eyelid/eyebrow surgery with the aim of improving symptoms were retrospectively reviewed over a 5-year period. Patients who had completed the Jankovic Rating Scale (JRS) and Blepharospasm Disability Index (BDI) pre- and at least 3 months postoperatively were included.
Results
Twenty-four patients were included. JRS scores significantly improved from 7.0 preoperatively to 4.1 postoperatively (p < 0.001), and BDI scores significantly improved from 18.4 preoperatively to 12.7 postoperatively (p < 0.001); the mean percentage improvements were 41% and 30%, respectively. Patients were followed for a median of 24 months postoperatively.
Conclusion
Periocular surgery significantly reduced BEB symptoms in the majority (83%) of patients by an average of 33% and may therefore be offered for suitable patients. An important minority (17%) of patients experienced symptom worsening.
-
Citations
Citations to this article as recorded by  - The long-term response to botulinum toxin injections in patients with blepharospasm undergoing upper eyelid surgery
Assunta Trinchillo, Nunzia Cuomo, Francesco Habetswallner, Marcello Esposito
Parkinsonism & Related Disorders.2024; 119: 105958. CrossRef - Blepharospasm Secondary to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Clinical Characteristics and Management Outcomes
Michelle A. Ting, Alexandra I. Manta, Emma Samia-Aly, Michelle Lai, Emanuel R. de Carvalho, Philip Buttery, Daniel G. Ezra
Journal of Neuro-Ophthalmology.2024; 44(4): 517. CrossRef
|
KMDS
E-submission
